Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intralymphatic Injection of Autoantigen in Type 1 Diabetes.

× No keyword cloud information.

17 in total

Review 1. Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.

Authors: Chunsong Yu; Jingchao Xi; Meng Li; Myunggi An; Haipeng Liu
Journal: Bioconjug Chem Date: 2017-12-06 Impact factor: 4.774

Review 2. Combination Immunotherapy for Type 1 Diabetes.

Authors: Robert N Bone; Carmella Evans-Molina
Journal: Curr Diab Rep Date: 2017-07 Impact factor: 4.810

Review 3. Linking autoantigen properties to mechanisms of immunity.

Authors: J Daniel Griffin; Jimmy Y Song; Joshua O Sestak; Brandon J DeKosky; Cory J Berkland
Journal: Adv Drug Deliv Rev Date: 2020-04-20 Impact factor: 15.470

Review 4. Designing natural and synthetic immune tissues.

Authors: Emily A Gosselin; Haleigh B Eppler; Jonathan S Bromberg; Christopher M Jewell
Journal: Nat Mater Date: 2018-05-21 Impact factor: 43.841

5. Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.

Authors: Meng Li; Arata Itoh; Jingchao Xi; Chunsong Yu; Yuehong Wu; William M Ridgway; Haipeng Liu
Journal: J Immunol Date: 2021-09-15 Impact factor: 5.426

Review 6. Engineering Immune Tolerance with Biomaterials.

Authors: Joshua M Gammon; Christopher M Jewell
Journal: Adv Healthc Mater Date: 2019-01-03 Impact factor: 9.933

Review 7. HLA variation and disease.

Authors: Calliope A Dendrou; Jan Petersen; Jamie Rossjohn; Lars Fugger
Journal: Nat Rev Immunol Date: 2018-01-02 Impact factor: 53.106

8. Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.

Authors: Beatriz Tavira; Hugo Barcenilla; Jeannette Wahlberg; Peter Achenbach; Johnny Ludvigsson; Rosaura Casas
Journal: J Diabetes Res Date: 2018-05-24 Impact factor: 4.011

Review 9. Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?

Authors: Rémi J Creusot; Jorge Postigo-Fernandez; Nato Teteloshvili
Journal: Diabetes Date: 2018-08 Impact factor: 9.461

Review 10. Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route.

Authors: Johnny Ludvigsson
Journal: Int J Mol Sci Date: 2020-02-26 Impact factor: 5.923